| |
V100%
|
V95%
|
V60 Gy
|
V30 Gy
|
D98%
|
D95%
|
D1cc
|
Dmean
|
|---|
|
PTVnx
|
|
Δ(%)
|
2.93 ± 5.03
|
−0.84 ± 1.59
| |
−1 ± 1.39
|
−0.67 ± 1.39
| |
0.02 ± 1.52
|
|
Range (%)
|
[−15.66,5.25]
|
[−6.25,1.23]
| |
[−3.82,1.34]
|
[−3.42,1.83]
|
[−2.93,2.97]
|
|
p
|
0.003
|
0.142
|
0.007
|
0.013
|
0.933
|
|
PTV1
|
|
Δ(%)
|
−0.37 ± .062
|
− 0.08 ± 0.16
| |
−1 ± 1.43
|
− 0.95 ± 1.32
| |
|
Range (%)
|
[−3.00,0.41]
|
[−0.63,0.04]
| |
[−4.58,0.78]
|
[−3.69,1.09]
| |
|
p
|
0.003
|
0.016
|
0.00
|
0.00
|
|
PTV2
|
|
Δ(%)
|
−0.37 ± 0.48
|
− 0.14 ± 0.20
| |
− 0.95 ± 1.43
|
− 0.19 ± 1.21
| |
|
Range (%)
|
[−1.26,1.10]
|
[−0.78,0.32]
| |
[−4.15,2.47]
|
[−2.96,3.19]
| |
|
p
|
0.000
|
0.001
|
0.001
|
0.39
|
|
Spinal Cord
|
|
Δ(%)
| |
0.62 ± 1.91
| |
|
Range (%)
|
[−3.22,6.66]
|
|
p
|
0.088
|
|
Brain Stem
|
|
Δ(%)
| |
−0.62 ± 1.2
| |
−0.73 ± 1.84
| |
|
Range (%)
|
[−3.49,0.34]
|
[−4.80,3.84]
|
|
p
|
0.008
|
0.039
|
|
Left Parotid Gland
|
|
Δ(%)
| |
−1.40 ± 2.59
| |
−1.33 ± 1.59
|
|
Range (%)
|
[−12.11,1.43]
|
[−4.69,2.00]
|
|
p
|
0.006
|
0.00
|
|
Right Parotid Gland
|
|
Δ(%)
| |
−1.27 ± 1.49
| |
−1.45 ± 1.54
|
|
Range (%)
|
[−4.78,2.16]
|
[−4.30,1.85]
|
|
p
|
0.000
|
0.000
|
|
Left Temporal Lobe
|
|
Δ(%)
| |
−1.40 ± 2.42
| |
|
Range (%)
|
[−9.42,3.90]
|
|
p
|
0.004
|
|
Right Temporal Lobe
|
|
Δ(%)
| |
−1.66 ± 3.49
| |
|
Range (%)
|
[−16.02,3.64]
|
|
p
|
0.014
|
|
Larynx
|
|
Δ(%)
| |
1.17 ± 1.58
|
|
Range (%)
|
[−2.43,5.08]
|
|
p
|
0.000
|
- Note. Δ(%) represents the relative deviation between the 3D reconstructed and planned doses (average ± standard deviation). p indicates significance on the two-tailed Student t-test
- Abbreviations:D
V
- volumetric dose and V
D
- dose volumes; PTV - planning target volume; OAR – organ at risk
